· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print) 2019 / N 4 Муковисцидоз: некоторые вопросы эпидемиологии и генетики С.А. Красовский, Т.А. Адян, Е.Л. Амелина, Д.Ф. Сергиенко, В.В. Шадрина, М.Ю. Гущин, О.Г. Зоненко, М.А. Макарова References 1. Elborn JS. Cystic fibrosis. The Lancet 2016 Nov;388(10059):2519-31. 2. Сystic fibrosis (Mucoviscidisis). Kapranov NI, Kashirskaya NY, editors. Moscow: Medpraktika-M; 2014.672 p. (In Russian). 3. Kerem BS, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. Identification of the cystic fibrosis gene: genetic analysis. Science 1989 Sep;245(4922):1073-80. 4. Barry PJ, Donaldson AL, Jones AM. Ivacaftor for cystic fibrosis. BMJ 2018 May 17;361:k1783. 5. Patel S, Sinha IP, Dwan K, Echevarria C, Schechter M, Southern KW. Potentiators for cystic fibrosis – targeting the underlying molecular defect. Paediatric Respiratory Reviews 2015 Jun;16(3):162-4. 6. Scotet V, Gillet D, Duguépéroux I, Audrézet MP, Bellis G, Garnier B, Roussey M, Rault G, Parent P, De Braekeleer M, Férec C; Réseau Mucoviscidose Bretagne et Pays de Loire. Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960. Human Genetics 2002 Sep;111(3):247-54. 7. des Georges M, Guittard C, Altiéri JP, Templin C, Sarles J, Sarda P, Claustres M. High heterogeneity of CFTR mutations and unexpected low incidence of cystic fibrosis in the Mediterranean France. Journal of Cystic Fibrosis 2004 Dec;3(4):265-72. 8. Bossi A, Casazza G, Padoan R, Milani S; Assemblea Dei Direttori Dei Centri. What is the incidence of cystic fibrosis in Italy? Data from the National Registry (1988-2001). Human Biology 2004 Jun;76(3):455-67. 9. Kollberg H. Incidence and survival curves of cystic fibrosis in Sweden. Acta Paediatrica Scandinavica 1982 Mar;71(2):197-202. 10. Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Archives of Disease in Childhood 1998 Jan;77(6):493-6. 11. Salvatore D, Buzzetti R, Baldo E, Forneris MP, Lucidi V, Manunza D, Marinelli I, Messore B, Neri AS, Raia V, Furnari ML, Mastella G. An overview of international literature from cystic fibrosis registries. Part 3. Disease incidence, genotype/phenotype correlation, microbiology, pregnancy, clinical complications, lung transplantation, and miscellanea. Journal of Cystic Fibrosis 2011 Mar;10(2):71-85. 12. Kusova ZA. Efficacy of newborns’ massive screening program for cystic fibrosis [Abstract from dissertation for the Degree of Candidate of Medical Sciences] 2011. 23 p. (In Russian). 13. Sherman VD, Kondratyeva EI, Voronkova AYu, Kashirskaya NYu, Shabalova LA, Nikonova VS, Zhekayte EK, Kutsev SI. Effect of neonatal screening for cystic fibrosis in patient groups of the Moscow region. Medical Council 2017;18:124-8 (In Russian). 14. Petrova NV. Molecular genetics and clinical genotype characteristics of cystic fibrosis in Russian populations [Abstract from dissertation for the Degree of Candidate of Biological Sciences] 2009. 42 p. (In Russian). 15. Register of cystic fibrosis patients in the Russian Federation. 2011. Russian Pulmonology. Supplement 2014. 43 p. Available from: https://mukoviscidoz.org/doc/registr/Registr_end_2011.pdf Accessed 2019 Dec 12. (In Russian) 16. Register of cystic fibrosis patients in the Russian Federation. 2017. Voronkova AYu, Amelina EL, Kashirskaya NYu, Kondratyeva EI, Krasovskiy SA, Starinova MA, Kapranov NI, editors. Moscow: Medpraktika-M; 2019. 68 p. (in Russian). 17. Grosse SD, Rosenfeld M, Devine OJ, Lai HJ, Farrell PM. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. The Journal of Pediatrics 2006;149(3):362-6. 18. Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. The Journal of Pediatrics 2009;155(6 Suppl):S73-93. 19. Vishnevskiy A. Demographic consequences of the great Patriotic War. Demographic Review 2016;3(2):3-42 (In Russian). 20. Register of cystic fibrosis patients in the Russian Federation. 2012. Russian Pulmonology. Supplement 2015. 60 p. (in Russian) Available from: http://mukoviscidoz.org/doc/registr/Registr_2012_27.02.pdf Accessed 2019 Dec 12. 21. Register of cystic fibrosis patients with in the Russian Federation. 2013. Moscow: Medpraktika-M; 2015. 63 p. (in Russian). 22. Register of cystic fibrosis patients in the Russian Federation. 2014. Moscow: Medpraktika-M; 2015. 64 p. (in Russian). 23. Kondrateyva EI, Krasovskiy SA, Voronkova AYu, Amelina EL, Chernyak AV, Kashirskaya NYu. Register of cystic fibrosis patients in the Russian Federation. 2015. Moscow: Medpraktika-M; 2016. 72 p. (In Russia). 24. Krasovskiy SA, Chernyak AV, Voronkova AYu, Amelina EL, Kashirskaya NYu, Kondratyeva EI, Gembitskaya TE. Register of cystic fibrosis patients in the Russian Federation. 2016. Moscow: Medpraktika-M; 2018. 64 p. (In Russian). 25. ECFS Patient Registry. Annual data report, 2017. Zolin A, Orenti A, Naehrlich L, van Rens J, Fox A, Krasnyk M, Jung A, Mei-Zahav M, Cosgriff R, Storms V, Naehrlich L, editors. Version 1.2019. Karup, Denmark: European Cyctic Fibrosis Society; 2019. 149 p. 26. Burgel PR. Epidemiological trends of cystic fibrosis in France: 10-year perspective. Archives de Pédiatrie 2016 Dec;23(12S):12S4-8. 27. Burgel PR, Bellis G, Olesen HV, Viviani L, Zolin A, Blasi F, Elborn JS. Future trends in cystic fibrosis demography in 34 European countries. European Respiratory Journal 2015;46(1):133-41. 28. Kashirskaya NYu, Krasovskiy SA, Chernyak AV, Sherman VD, Voronkova AYu, Shabalova LA, Nikonova VS, Gorinova YuV, Simonova OI, Amelina EL, Kondratyeva EI, Kapranov NI, Petrova NV, Zinchenko RA. Dynamics of life expectancy of cystic fibrosis patients in Moscow and its connection with therapy received: retrospective analysis for 1993-2013. Current Pediatrics 2015;14(4):503-8 (In Russian). 29. Stephenson A, Sykes J, Stanojevic S, Quon B, Marshall B, Petren K, Ostrenga J, Fink A, Elbert A, Goss C. Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study. Annals of Internal Medicine 2017;166(8):537-46. 30. Cystic fibrosis mutation database. Available from: http://genet.sickkids.on.ca Accessed 2019 Dec 12. 31. Petrova NV, Marakhonov AYu, Vasilyeva TA, Kashirskaya NYu, Kondratyeva EI, Zhekaite EK, Voronkova AYu, Sherman VD, Ginter EK, Kutsev SI, Zinchenko RA. Spectrum of mutations detected in complex study of CFTR gene in Russian cystic fibrosis patients. Almanac of Clinical Medicine 2019;47(1):38-46 (In Russian). 32. Gorinova YuV, Savostyanov KV, Pushkov AA, Nikitin AG, Penkov EL, Krasovskiy SA, Simonova OI, Namazova-Baranova LS. Genotype-phenotype correlations of cystic fibrosis in Russian children. The first description of eleven new mutations. Current Pediatrics 2018;17(1):61-9 (In Russian). 33. Pereira SV, Ribeiro JD, Ribeiro AF, Bertuzzo CS, Marson FAL. Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools. Science Reports 2019;9(1):6234. 34. Genome aggregation database. Available from: http://gnomad.broadinstitute.org Accessed 2019 Dec 12. 35. NHLBI Exome Sequencing Project (ESP). Available from: http://evs.gs.washington.edu/EVS/ Accessed 2019 Dec 12. 36. DbSNP. Available from: http://www.ncbi.nlm.nih.gov/snp Accessed 2019 Dec 12. 37. DbVar. Available from: http://www.ncbi.nlm.nih.gov/dbvar Accessed 2019 Dec 12. 38. OMIM. Available from: http://www.omim.org/ Accessed 2019 Dec 12. 39. The Human Gene Mutation Database. Available from: http://www.hgmd.cf.ac.uk/ac/index.php Accessed 2019 Dec 12. 40. Clinical and Functional TRanslation of CFTR (CFTR2). Available from: https://www.cftr2.org Accessed 2019 Dec 12. 41. Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, Race V, Sistermans E, Sturm M, Weiss M, Yntema H, Bakker E, Scheffer H, Bauer P; EuroGentest; European Society of Human Genetics. Guidelines for diagnostic next-generation sequencing. European Journal of Human Genetics 2016 Jan;24(1):2-5. 42. Ryzhkova OP, Kardymon OL, Prokhorchuk EB, Konovalov FA, Maslennikov AB, Stepanov VA, Afanasyev AA, Zaklyazminskaya EV, Kostareva AA, Pavlov AE, Golubenko MV, Polyakov AV, Kutsev SI. Guidelines to interpretation data obtained by massive parallel sequencing (MPS) variants. Medical Genetics 2017;16(7):4-17 (In Russian). 43. Southern KW, Patel S, Sinha IP, Nevitt SJ. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis. Cochrane Database of Systematic Reviews 2018 Aug;(8):CD010966. 44. Castellani C, Cuppens H, Macek M Jr, Cassiman JJ, Kerem E, Durie P, Tullis E, Assael BM, Bombieri C, Brown A, Casals T, Claustres M, Cutting GR, Dequeker E, Dodge J, Doull I, Farrell P, Ferec C, Girodon E, Johannesson M, Kerem B, Knowles M, Munck A, Pignatti PF, Radojkovic D, Rizzotti P, Schwarz M, Stuhrmann M, Tzetis M, Zielenski J, Elborn JS. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. Journal of Cystic Fibrosis 2008 May;7(3):179-96. 45. De Boeck K, Amaral MD. Progress in therapies for cystic fibrosis. The Lancet. Respiratory Medicine 2016 Aug;4(8):662-74. 46. Veit G, Avramescu RG, Chiang AN, Houck SA, Cai Z, Peters KW, Hong JS, Pollard HB, Guggino WB, Balch WE, Skach WR, Cutting GR, Frizzell RA, Sheppard DN, Cyr DM, Sorscher EJ, Brodsky JL, Lukacs GL. From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Molecular Biology of the Cell 2016 Feb;27(3):424-33. 47. CFF Patient Registry. Annual data report, 2018. Bethesda, Maryland: Cystic Fibrosis Foundation; 2019. 92 p. 48. Krasovskiy SA, Kashirskaya NYu, Chernyak AV, Amelina EL, Petrova NV, Polyakov AV, Kondratyeva EI, Voronkova AYu, Usacheva MV, Adyan TA, Stepanova AA, Alimova IL, Asherova IK, Baykova GV, Basilaya AV, Boytsova EV, Borisov AV, Brisin VYu, Vasilyeva EA, Vasilyeva TG, Vodovozova EV, Voronin SV, Gaymolenko IN, Golubtsova OI, Gorinova YuV, Nazarenko LP, Odinokova ON, Gembitskaya TE, Nikonova VS, Dyachkova AA, Sergiyenko DF, Yenina EA, Yerzutova MV, Zinchenko YuS, Zonenko OG, Ivanova DM, Ilyenkova NA, Kadyrova DV. Genetic characterization of cystic fibrosis patients in the Russian Federation according to the National Register, 2014. Russian Pulmonology 2016;26(2):133-51. (In Russian). 49. Makarov AKh, Petrova NV, Timkovskaya EE, Vasilyeva TA, Kashirskaya NYu, Kondratyeva EI, Zinchenko RA. Spectrum of CFTR mutations in Karachay-Cherkessia. Current Problems of Science and Education 2016;2:28 (In Russian).    [ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]